Negotiating the changing NHS landscape: five critical shifts the pharma industry must embrace
As the long-awaited Health and Care Bill begins its passage through parliament, Oli Hudson looks at five critical changes resulting from these reforms that...
Setting the scene: sarcoma diagnosis and treatment
July marks Sarcoma Awareness Month and the 10th anniversary of the bone and soft tissue cancer charity, Sarcoma UK. To mark their anniversary, the...
Genetic variants identified that impact immune cells’ functioning
Genetic variants have been identified that impact immune cells' functioning. Certain genetic variants that cause modified protein binding in immune cells, are also seen...
New transatlantic cancer research partnership
The two largest funders of cancer research in the world are set to make radical progress against cancer with a new scientific cancer research...
Pancreatic Cancer Story: John William Street
Pancreatic cancer is the 10th most common cancer in the UK, with around 10,000 people diagnosed each year. The disease has the lowest survival...
Building the trust – post COVID-19
Simon Grime, Executive Director at Wilmington Healthcare discusses what needs to be done to build trust between pharma and health in a post COVID-19...
The new NHS stakeholder map
Paul Midgley, of Wilmington Healthcare, looks at the new NHS stakeholder map and explores the latest changes in NHS structure, which were outlined in...
Government creates new National Institute for Health Protection
The Government has created the National Institute for Health Protection, a brand new organisation whose primary focus is public health protection and infectious disease...
Diabetes inpatient care during COVID-19
A new Diabetes UK review into diabetes inpatient care during COVID-19 has revealed that disruption to inpatient diabetes services created positive environments and opportunities...
The King’s Fund comments on NHS performance data
The King's Fund has commented on the monthly NHS performance data on accident and emergency, referral to treatment and diagnostics which shows the impact...
Latest articles
PM Society Digital Awards Winners 2021
Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
New patient coalition launched for digital health technology
A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
How to digitalise MSL teams for increased efficiency
Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
New patient coalition launched for digital health technology
A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
PM Society Digital Awards Winners 2021
Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
Sandoz in commercial agreement with Bio-Thera Solutions for biosimilar bevacizumab
Sandoz, a Novartis division, has strengthened its pipeline by entering into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706) for the...
How to digitalise MSL teams for increased efficiency
Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...